NR2F2 is a ligand-activated nuclear receptor that functions as a transcription factor regulating diverse developmental and pathological processes. The protein binds retinoic acids (9-cis and all-trans) and regulates transcription through both activation and repression of target genes. During early human development, NR2F2 marks trophectoderm maturation beginning at the blastocyst stage and continuing after implantation 1. The gene plays essential roles in gonad development and cardiovascular patterning; heterozygous loss-of-function variants cause a recognizable multiple congenital anomaly syndrome featuring congenital heart defects, developmental delays, genital anomalies, and hypotonia 2. Beyond development, NR2F2 functions as a cancer stem cell regulator. In squamous cell carcinomas, NR2F2 promotes malignancy by sustaining tumor stemness, driving epithelial-mesenchymal transition, and repressing differentiation 3. Similar stemness-promoting functions occur in esophageal and oral squamous cell carcinomas, where NR2F2 upregulation associates with lymph node metastasis [PMID:40645396; 45]. Additionally, NR2F2 participates in stress responses: in Parkinson's disease, a vulnerable dopamine neuron subtype shows upregulation of NR2F2 targets 5, and in the amygdala, NR2F2 mediates stress-induced fear behavior through neuroimmune interactions 6. Emerging evidence suggests NR2F2 modulates metabolic homeostasis, repressing oxidative phosphorylation under hyperglycemic stress in skin 7 and facilitating vascular endothelial differentiation in pulmonary hypertension 8. These diverse roles position NR2F2 as a central transcriptional hub linking development, cancer biology, and stress physiology.